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Abstract
Hepatocellular carcinoma (HCC) and hep-
atoblastoma (HB) are malignancies of the liver
with different etiologies, but the HB cell line
HepG2 has been frequently used in various
studies of HCC. In this study, we compare the
protein expression patterns between HepG2
cells and three HCC cell lines, HKCI-2, HKCI-
3, and HKCI-4, respectively. The cell lysates of
individual cell lines were separated by two-
dimensional polyacrylamide gel electrophore-
sis. The protein spots in the gel images were
quantified and compared by image analysis
software. The differentially expressing proteins
were then identified by tryptic peptide mass
fingerprinting. Compared with the HepG2
cells, the normalized quantities of 49 and 58
protein spots were found to be at least twofold
higher and twofold lower, respectively, in 
all three HCC cell lines. The differentially
expressed proteins can be grouped into struc-
tural proteins (annexins, transgelin, laminin
receptor), stress-induced proteins (HSP27, 60,
and 70), enzymes (aldehyde dehydrogenase,
pyruvate kinase, -enolase, etc.), and tran-
scription factors (far upstream element binding
protein 2, GTP-binding nuclear protein RAN).
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Introduction
Primary liver malignancies can be grouped
into different types according to the lineage of
transformed cells, histology, and various
pathological parameters. Hepatocellular carci-
noma (HCC) is the fifth most common cancer
in the world and is the third leading cause of
cancer death (1). About three-quarters of the
cases of HCC are found in southeast Asia
(China, Hong Kong, Taiwan, Korea, and
Japan). In addition, HCC is also very common
in sub-Saharan Africa (Mozambique and
South Africa). HCCs originate from hepato-
cytes. It is well known that hepatitis B virus
(HBV) infection, hepatitis C virus (HCV) infec-
tion, liver cirrhosis, and exposure to carcino-
gens such as aflatoxin B1 are risk factors for
HCC (2).
Hepatoblastoma (HB) is another type of
liver malignancy. Different from HCC, it is an
embryonal tumor derived from undifferenti-
ated embryonal tissue. Although its etiology
remains unclear, it usually occurs in childhood
with an annual incidence of 0.5–1.5 diagnoses
per 1 million children younger than 15 yr of
age in Western countries (3). The incidence
rate of HB is higher in patients with the Beck-
with-Wiedemann syndrome or familial adeno-
matous polyposis (4,5).
Cancer cell lines are commonly used as in
vitro models for various types of cancer stud-
ies, including studies of carcinogenesis, poten-
tial antitumor drugs, and biomarker discovery.
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Advantages of using cell line models are that
they are homogenous and their supplies are
virtually unlimited. HepG2 is an HB cell line,
derived from the HB tissue of a 15-yr-old male
Caucasian. It has been frequently used as an in
vitro cell line model in HCC-related studies,
resulting in >500 reports (6) and occasionally
has been wrongly regarded as an HCC cell line.
The present study aimed to compare the pro-
tein expression patterns between HepG2 cells
and three well-characterized HCC cell lines
derived from HCC tumor tissues. The findings
of this study could help in understanding the
differences in the cellular properties between
HCC and HB and in answering whether HepG2
is an appropriate model for studies of HCC.
Materials and Methods
Cell Cultures
The HepG2 cells were obtained from 
American Type Culture Collection (ATCC)
and cultured as recommended. The HCC cell
lines used in this study are the three cell lines
(HKCI-2, HKCI-3, HKCI-4) previously estab-
lished by us (7). They were cultured as previ-
ously described (7). All three HCC cell lines
were derived from the HCC tissues of patients
with chronic HBV infection and/or liver 
cirrhosis. HKCI-4 cells expressed HBV core
gene product. Immunohistochemical staining
showed that all three HCC cells were of
epithelial origin. Clinicopathological data of
the two types of cell lines are listed in Table 1.
Sample Preparations
The HepG2 and HCC cells were cultured 
to about 60–70% confluence. The cells were
Some of these proteins play important roles 
in regulating homeostasis, drug resistance,
apoptosis, cell differentiation, cell growth, and
metastasis. In conclusion, our proteomic data
indicate that there are considerable differences
in the protein expression patterns between
HepG2 cells and the HCC cells, suggesting dif-
ferences in cellular properties. Hence, HepG2
may not be a good cell line model for study-
ing HCC.
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Table 1
Clinicopathologic Data in Patients, Primary Liver Cancers, and the Corresponding Cell Lines 
Serological HBV core HBV surface 
Cirrhosisa viral status geneb (primary geneb (primary HBV core geneb HBV surface
Cell lines (patient liver) (patient serum) tumor) tumor) (cell line) geneb (cell line)
HepG2 NA NA NA NA  
HKCI-2      
HKCI-3  HBV    
HKCI-4  HBV    
Information about hepatocellular carcinoma (HCC) cell lines was as published (7). Information about HepG2
cells is available from American Type Culture Collection. NA, not available.
aCirrhosis = the presence of underlying liver cirrhosis. 
bHepatitis B virus (HBV) status for HCC cell lines was confirmed by nested PCR analysis for the presence of
HBV core and surface genes 7.
washed twice with Hanks buffer supplemented
with 20 mM HEPES (pH 7.0) and once with 
10 mM Tris-Cl (pH 7.0) containing 250 mM
sucrose. The cells were lysed in cell lysis buffer
(8 M urea, 40 mg/mL CHAPS, 40 mM Tris, and
65 mM dithiothreitol [DTT]) with the use of a
sample grinding kit (Amersham Biosciences,
Piscataway, NJ) and a hand-held motor. The
protein concentrations of each sample were
quantified with the two-dimensional gel elec-
trophoresis (2-DE) quantification kit (Amer-




The cell lysates were subjected to isoelectric
focusing (IEF; the first dimensional separation)
on a PROTEAN IEF cell (Bio-Rad, Hercules,
CA). Eighty micrograms of total cellular protein
of each cell lysate was mixed with IEF rehydra-
tion buffer (Bio-Rad) to a final volume of 300
L. A 17-cm immobilized pH 3.0–10.0 nonlinear
gradient IPG immobilin strip was passively
rehydrated with the mixture for 16 h. IEF was
carried at 20°C under programmed stepwise
conditions: 100 V, 50 Vh; 200 V, 200 Vh; 500 V,
500 Vh; 1000 V, 1000 Vh; 8000 V, 24,000 Vh.
After IEF, the IPG strip was washed briefly with
water and equilibrated for 15 min in 6 M urea,
0.375 M Tris-Cl at pH 8.0, 0.02 g/mL SDS, 20%
glycerol (v/v), and 1 mg/mL DTT. Then the
strip was equilibrated in 6 M urea, 0.375 M Tris-Cl
at pH 8.0, and 20% glycerol with 40 mg/mL
iodoacetamide (IAA; Sigma, St. Louis, MO).
Finally, the strip was equilibrated in 6 M urea,
0.375 M Tris-Cl at pH 8.0, 0.02 g/mL SDS, and
20% glycerol (v/v) for 10 min. For the second
dimension separation, 8–16% gradient gel (Bio-
Rad) was used. SDS-PAGE was performed on
the Protean XL system (Bio-Rad). The gels were
stained with the Plus-one silver staining kit
(Amersham) according to the manufacturer’s
instructions. Developing time was controlled to
avoid saturation. Each sample was analyzed at
least twice.
Image Acquisition and Data Analysis
The stained gels were scanned with a densito-
meter GS-700 (Bio-Rad) as raw 2-DE images.
After scanning, all the gels were stored at 4°C
before further analysis. The gel images were
processed and compared using the PDQuest
software (version 7.11, Bio-Rad). On each gel
image, the intensity of each spot was normal-
ized against the total intensity of all valid
spots. Protein quantities of twofold up- 
or downregulation between the two groups
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were considered as differentially expressed
spots.
Protein Identification by Peptide Mass
Fingerprinting
The protein spots of interests were excised
from the gels and placed into Eppendorf
tubes. The gel pieces were first washed with
milli-Q water, destained with a freshly pre-
pared mixture of 1:1100 mM sodium thiosul-
fate and 30 mM potassium ferricyanide (III).
Then the gel pieces were sequentially washed
with milli-Q water, 50% methanol, 10% acetic
acid, and 25 mM NH4HCO3. Afterward, the
proteins in the gels were reduced with 10 mM
DTT and subsequently alkylated with 50 mM
IAA in 25 mM NH4HCO3. The gel pieces were
washed again with 25 mM NH4HCO3, dehy-
drated with 25 mM NH4HCO3 in 80:20 ace-
tonitrile (ACN)/water. After drying, the gel
pieces were rehydrated with digestion buffer
(0.1 mg/mL n-octylglucoside in 25 mM
NH4HCO3, pH 8.0) containing 50 ng of
sequencing grade trypsin (Sigma). Digestion
was carried out at 37°C overnight. Digested
peptides were extracted twice with 70:30
ACN/water containing 0.1%  trifluoroacetic
acid (v/v). The recovered peptides were spot-
ted on a matrix-assisted laser desorption/ion-
ization time-of-flight mass spectrometry
(MALDI-TOF MS) sample plate and overlaid
with -cyano-4-hydroxycinnamic acid as
matrix. All the samples were detected with the
Voyager DETM-Pro MALDI-TOF MS system
(Applied Biosystems, Foster City, CA). The
acquired masses were externally calibrated
with peptide mass standards (Applied Bio-
systems) and internally calibrated with trypsin
autolyzed peptides. The acquired masses were
submitted to PROFOUND (www.prowl.
rockerfeller.edu/cgi-bin/ProFound) for pro-
tein database matching. A protein identification
was considered successful when the PRO-
FOUND probability score was 1.0 and the esti-
mated Z score was higher than 1.65 (8).
Results
Figure 1 shows the representative gel
images of HepG2, HKCI-2, HKCI-3, and
HKCI-4, respectively. On average, about 1300
protein spots from each cell line were
detected. Compared with the HepG2 cells, the
normalized quantities of 49 and 58 protein
spots were found to be at least twofold higher
and twofold lower, respectively, in all three
HBV-associated HCC cell lines.
The differentially expressed spots were
excised from the gels and subjected to peptide
mass fingerprinting analysis. Protein identities
of 30 protein spots were successfully obtained.
The protein identities of the differentially
expressed proteins and their relative abundances
are summarized in Table 2. For those proteins
with isoforms, the relative abundances of indi-
vidual isoforms are also listed. Our experimental
molecular weight/isoelectric point (Mr/pI)
values of the identified proteins matched with
theoretical Mr/pI values and the experimental
Mr/pI values reported by Seow et al. (9).
Figure 2 shows a zoom-view of the gel
images. Isoforms of GTP:ATP phosphotrans-
ferase, and dehydrogenase/reductase SDR
family member 2, and GTP-binding nuclear pro-
tein RAN were upregulated in HepG2, whereas
GTP-binding nuclear protein RAN, phospho-
glycerate mutase isozyme B, glyceraldehyde 
3-phosphate dehydrogenase, transgelin 2, and
isoforms of annexin II were upregulated in HCC
cell lines. The differentially expressed proteins
can be categorized as structural proteins, heat
shock proteins (HSPs), metabolic enzymes, and
transcription factors (Table 3).
Discussion
Conventional cytogenetic studies, compara-
tive genomic hybridization studies, and PCR-
based microsatellite studies showed significant
differences in the chromosomal changes
between HB and HCC (24). HBs are character-
ized by a low number of chromosomal changes,
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not be the best choice for quantitative exper-
iments, it is widely accepted for semiquanti-
tative analysis. Silver staining has a linear
dynamic range of >50-fold (26). After nor-
malization, the coefficients of variation of the
quantities of the silver-stained protein spots
are between 15 and 25% (27,28), comparable
to the values obtained by SYPRO Rudy
staining.
We carefully reviewed previous studies on
gene/protein expression patterns of HCC and
liver cells/tissues. Some of these differentially
expressed proteins had been identified in other
HCC cell lines, hepatocytes, and serum/tissues
whereas HCCs have multiple chromosomal
abnormalities. Our recent spectral karyotyping
study also revealed that the chromosomal
abnormalities that commonly occurred in HCCs
did not present in HepG2 cells (25). In this
study, we also found significant differences in
the expression levels of various proteins
between HepG2 cells and HCC cells: those
involved in various cellular functions including
homeostasis, metabolism, cellular structure,
gene transcription regulation, and apoptosis.
We used 2D-PAGE coupled with silver
staining to find out the differences between
HCC and HB. Although silver staining may
Fig. 1. Representative gel images of HepG2 and hepatocellular carcinoma cell lines. The boxes indicate the
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of HCC patients. The expression patterns of
these proteins in liver, other cell lines, and
tissues are listed in Table 3. Our findings are
consistent with those of other investigators;
for example, in our study, HSP27 is highly
expressed in HCC cell lines but not in HepG2
cells. This protein is also highly expressed in
an HBV-associated HCC-M cell line and in a
BEL-7404 HCC cell line (11,12,14). HepG2
expressed a high level of HSP27 only when it
was stably transfected with hepatitis B viral
X protein. Laminin receptor is highly ex-
pressed in the HCC cell lines examined but
not in HepG2 cells. This protein is also highly
expressed in an HCC-M cell line (11) but is
not found in HepG2 cell membrane (19).
Another example is that dehydrogenase/re-
ductase is highly expressed in HepG2 cells
but not in HCC cell lines in our study. This
protein was reported to be expressed in
HepG2 (22).
Table 4 shows the biological roles of the dif-
ferentially expressed proteins related to HBV
and carcinogenesis. The HSPs were differen-
tially expressed between the HepG2 and the
HCC cell lines. HSPs are a group of highly
conserved proteins; they can be classified
according to their molecular masses into four
major families: small, low-molecular-weight
HSP (sHSP), HSP60, HSP70, and HSP90. They
are synthesized by cells and tissues in re-
sponse to heat and various stress conditions
including carcinogenesis. HSPs are usually
highly expressed in many types of tumor.
HSPs act as molecular chaperones; they can
protect proteins from degradation and en-
hance protein refolding, thus inhibiting apop-
tosis and enhancing cell survival under stress
Proteomic Comparison of HCC and Hepatoblastoma ______________________________________________ 321
Fig. 2. Zoom views of a representative region in gel images showing differential expressions of the proteins in
HepG2 cells and hepatocellular carcinoma (HCC) cells.Arrows indicate the proteins that had twofold higher
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conditions such as a drug challenge (71). HSPs
are differentially expressed between the HCC
cell lines and the HepG2 cell line. Thus, their
properties in drug resistance, apoptosis, and
invasiveness may be different.
For structural proteins, laminin receptor
and annexin II are upregulated in HCC cells,
and these two proteins were also expressed in
HCC-M cell lines (11,20). There is much evi-
dence to indicate that the 67-kDa laminin
receptor is important in the progression of a
wide variety of carcinomas (72). Annexins are
Ca2+ and phospholipid binding proteins that
have been implicated in the regulation of exo-
cytic and endocytic pathways. Expression of
annexin II was demonstrated in HCC and was
not detected in normal liver extracts (73). Both
laminin receptor and annexin II are associated
with drug-resistance properties (Table 4).
Laminin receptor is HBV associated; its upreg-
ulation is a signal of increasing invasiveness
in HBV-associated HCC (74). Laminin recep-
tor is highly expressed in the HCC-M cell (11)
and also in our HCC cells, whereas Zheng
et al. (19) demonstrated very low expression
levels of membrane laminin receptor in HepG2
cells. Moreover, annexin is also involved in apop-
tosis. Thus, the apoptotic and drug-resistance
properties of HepG2 and HCC cell lines
should be different.
Expression levels of metabolic enzymes are
commonly altered in carcinoma tissues.
Several enzymes involved in the glycolytic
pathway were upregulated in HCC cell lines.
Aldose A, glyceraldehyde-3-phosphate dehy-
drogenase, phosphoglycerate mutase, and
pyruvate kinase were upregulated in HCC cell
lines. This indicates that the cell lines may
have different metabolic properties. In addi-
tion, -enolase, aldehyde dehydrogenase,
pyruvate kinase, and NADPH: adrenodoxin
oxidoreductase are involved in drug me-
tabolism. These differentially expressed pro-
teins reflect the different properties of the 
cell lines.
Proteomic Comparison of HCC and Hepatoblastoma ______________________________________________ 327
Far upstream element binding protein 2 and
GTP-binding nuclear protein RAN are upreg-
ulated in HCC cell lines. These two proteins
are involved in transcription and growth
regulation. Far upstream element binding
protein 2 is also involved in cell differentia-
tion (70), thus indicating that the two types
of cells are using different growth regulatory
mechanisms.
In conclusion, proteins involved in regulat-
ing homeostasis, drug resistance, apoptosis, cell
differentiation, cell growth, and metastasis were
differentially expressed in the HCC cell lines
and in HB cell line HepG2. Hence, HepG2 may
not be a good cell line model for studying
HCC. Our results also suggest that the cellular
properties of HCC and HB are different.
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